LAWRENCE, Mass., Feb. 22 /PRNewswire-FirstCall/ -- NxStage Medical, Inc. today announced that Jeffrey Burbank, President and CEO, and David Gill, Senior Vice President and Chief Financial Officer, are scheduled to present at the JMP Securities 5th Annual Research Conference on March 7, 2006 at 11:00 am at the Ritz-Carlton Hotel in San Francisco, CA.
A live webcast and recording of the NxStage presentation will be available at http://www.wsw.com/webcast/jmp2/nxtm.
About NxStage Medical
NxStage Medical, Inc. is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative systems for the treatment of end-stage renal disease, or ESRD, and acute kidney failure. For more information on NxStage and its products, please visit the company’s website at http://www.nxstage.com.
Contact David N. Gill Senior Vice President & Chief Financial Officer 978-687-4700 dgill@nxstage.com
NxStage Medical, Inc.
CONTACT: David N. Gill, Senior Vice President & Chief Financial Officer ofNxStage Medical, Inc., +1-978-687-4700, dgill@nxstage.com
Web site: http://www.nxstage.com/
